Fatal Case of Candidemia due to Candida glabrata

CC BY-NC-ND 4.0 · J Lab Physicians 2014; 6(01): 063-064
DOI: 10.4103/0974-2727.129098

Letters to Editor

Sidhartha Giri

Department of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu, India

,

Anupma Jyoti Kindo

Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Chennai, Tamil Nadu, India

,

J Kalyani

Department of Microbiology, Sri Muthukumaran Medical College, Chennai, Tamil Nadu, India

REFERENCES
1 Rex JH, Ghannoum MA, Alexander BD, Andes D, Brown SD, Diekema DJ. In: Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved guideline M44-A2. M44-A2[24]. Pennsylvania, USA: CLSI; 2009. Ref Type: Serial (Book, Monograph).
2 Malani A, Hmoud J, Chiu L, Carver PL, Bielaczyc A, Kauffman CA. Candida glabrata fungemia: Experience in a tertiary care center. Clin Infect Dis 2005;41:975-81.
3 Xess I, Jain N, Hasan F, Mandal P, Banerjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 2007;35:256-9.
4 Sanglard D, Ischer F, Monod M, Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 1997;143:405-16.
5 Borst A, Raimer MT, Warnock DW, Morrison CJ, Arthington-Skaggs BA. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole. Antimicrob Agents Chemother 2005;49:783-7.
6 Sanguinetti M, Posteraro B, Fiori B, Ranno S, Torelli R, Fadda G. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance. Antimicrob Agents Chemother 2005;49:668-79.